CN113907152A - Processing technology of ganoderma lucidum fermented tea - Google Patents
Processing technology of ganoderma lucidum fermented tea Download PDFInfo
- Publication number
- CN113907152A CN113907152A CN202111164339.1A CN202111164339A CN113907152A CN 113907152 A CN113907152 A CN 113907152A CN 202111164339 A CN202111164339 A CN 202111164339A CN 113907152 A CN113907152 A CN 113907152A
- Authority
- CN
- China
- Prior art keywords
- ganoderma lucidum
- leaves
- tea
- ganoderma
- moringa oleifera
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 72
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 72
- 235000019225 fermented tea Nutrition 0.000 title claims abstract description 23
- 238000005516 engineering process Methods 0.000 title claims abstract description 17
- 238000012545 processing Methods 0.000 title claims abstract description 16
- 244000269722 Thea sinensis Species 0.000 claims abstract description 57
- 235000013616 tea Nutrition 0.000 claims abstract description 51
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 48
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 48
- 241000222336 Ganoderma Species 0.000 claims abstract description 17
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 241001076416 Dendrobium tosaense Species 0.000 claims description 28
- 241000521581 Millettia Species 0.000 claims description 28
- 240000000249 Morus alba Species 0.000 claims description 28
- 235000008708 Morus alba Nutrition 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 19
- 238000012258 culturing Methods 0.000 claims description 14
- 238000002791 soaking Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 9
- 229920001817 Agar Polymers 0.000 claims description 7
- 241001489091 Ganoderma sinense Species 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 244000061456 Solanum tuberosum Species 0.000 claims description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 7
- 239000008272 agar Substances 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000758 substrate Substances 0.000 abstract 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 229960001031 glucose Drugs 0.000 description 7
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 241000233866 Fungi Species 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000020279 black tea Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 235000020334 white tea Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
- A23F3/10—Fermentation with addition of microorganisms or enzymes
Abstract
The invention discloses a processing technology of lucid ganoderma fermented tea, which specifically comprises the following steps: 1) cleaning the fermentation substrate; 2) cultivating ganoderma lucidum mycelia; 3) cultivating Moringa oleifera and Ganoderma lucidum; 4) inoculating the moringa oleifera and ganoderma lucidum in the step 3) into the substrate in the step 1) to prepare the ganoderma lucidum fermented tea. The invention belongs to the technical field of tea, and particularly relates to a processing technology of ganoderma lucidum fermented tea.
Description
Technical Field
The invention belongs to the technical field of tea, and particularly relates to a processing technology of ganoderma lucidum fermented tea.
Background
With the social development, the life style of people is changed, the life quality is continuously improved, meanwhile, factors such as overnutrition, lack of exercise and the like comprehensively influence the metabolism of human bodies, the incidence rates of diabetes, gout and hyperlipidemia are increased year by year in the global range, blood diseases cannot be cured, the course of treatment is long, the treatment is difficult, and the traditional Chinese medicine becomes one of important diseases threatening the health of human beings.
The tea is a natural beverage, has multiple health care functions, and is one of three traditional beverages in the world. Modern scientific research shows that tea contains more than 450 organic compounds and more than 15 inorganic minerals. Our ancestors have long recognized that drinking tea can strengthen the body and eliminate diseases, and the compendium of materia medica records: "tea" is a medicine for all diseases. The old people with long life in tea-producing areas often drink tea to achieve the purpose of reducing blood pressure, blood fat and blood sugar; but only the tea leaves have small effects on reducing blood pressure, blood fat and blood sugar.
Ganoderma is also called Ganoderma lucidum, Ganoderma sinense, and is whole plant of Ganoderma lucidum or Ganoderma sinense of Polyporaceae. It is called as the superior product by Benjing. Ganoderma lucidum is called as 'immortal grass' and 'Ruilao' since ancient times, and the traditional Chinese medicine is a precious Chinese herbal medicine for nourishing, strengthening the body and strengthening the body resistance for a long time. Ganoderma polysaccharides, Ganoderma polypeptide, adenosine, triterpene, etc. in Ganoderma have effects of repairing and promoting division and growth of variant cells in human body.
The ganoderma lucidum is combined with the tea leaves to prepare the ganoderma lucidum fermented tea, has the effects of the tea leaves and the ganoderma lucidum, can be used for adjuvant therapy of the diseases after being drunk for a long time, and has the health-care effect.
Disclosure of Invention
The invention aims to provide a processing technology of ganoderma lucidum fermented tea, which aims to solve the problems in the background technology.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows: a processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, fishing out and draining off water, then carrying out sterilization treatment at the temperature of 200-220 ℃, wherein the tea leaves can be one of green tea, rock tea, black tea, white tea and oolong tea according to the difference of tastes of consumers;
2) collecting Ganoderma, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma strain;
3) packaging the crushed moringa oleifera scraps, sterilizing at the temperature of 200-220 ℃, inoculating ganoderma lucidum strains as a fermentation base material, and culturing at the temperature of 28 ℃ for 28 days to obtain moringa oleifera ganoderma lucidum strains;
4) inoculating moringa oleifera and ganoderma lucidum into the sterilized beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale of the step 1) which are used as fermentation base materials, and fermenting for 30 days at the temperature of 30-35 ℃ to obtain the ganoderma lucidum fermented tea.
Preferably, the ganoderma lucidum in the step 2) is purple ganoderma lucidum or red ganoderma lucidum.
Preferably, the mass ratio of the ganoderma lucidum strains to the spicy sawdust in the step 3) is 1: 100.
Preferably, the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the moringa oleifera ganoderma lucidum in the step 4) comprise the following components in parts by weight: 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera and ganoderma lucidum.
The invention adopts the scheme to obtain the following beneficial effects: by the method, the lucid ganoderma and the tea are organically combined to prepare the lucid ganoderma fermented tea, the lucid ganoderma fermented tea has the advantages of the tea and the lucid ganoderma, and can play a role in adjuvant therapy of hematopathy after being drunk for a long time, and can play a role in health care and improving immune function after being drunk by normal people for a long time.
Detailed Description
The technical solutions of the present invention will be described in further detail with reference to specific embodiments, and all the portions of the present invention not described in detail are the prior art.
The present invention will be described in further detail with reference to examples.
Example 1
A processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, fishing out and draining water, then carrying out sterilization treatment at 220 ℃ under 200 plus materials, wherein the tea leaves are green tea;
2) collecting Ganoderma, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma strain;
3) packaging the crushed moringa oleifera chips, sterilizing at the temperature of 200-220 ℃, taking the crushed moringa oleifera chips as a fermentation base material, inoculating a ganoderma sinense strain, culturing at the temperature of 28 ℃ for 28 days with the mass ratio of the ganoderma sinense strain to the moringa oleifera chips being 1:100, and obtaining moringa oleifera-ganoderma lucidum strain;
4) taking the beautiful millettia root leaves, the tea leaves, the mulberry leaves and the dendrobium officinale which are sterilized in the step 1) as fermentation base materials, and inoculating the purple moringa oleifera fungus, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the purple moringa oleifera fungus comprise the following components in parts by weight: 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera and ganoderma lucidum, and fermenting for 30 days at the temperature of 30 ℃ to obtain ganoderma lucidum fermented green tea.
Example 2
A processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, taking out and draining water, then carrying out sterilization treatment at 220 ℃ under 200 plus materials, and selecting rock tea as tea leaves;
2) collecting Ganoderma, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma strain;
3) packaging the crushed moringa oleifera chips, sterilizing at the temperature of 200-220 ℃, taking the crushed moringa oleifera chips as a fermentation base material, inoculating a ganoderma sinense strain, culturing at the temperature of 28 ℃ for 28 days with the mass ratio of the ganoderma sinense strain to the moringa oleifera chips being 1:100, and obtaining moringa oleifera-ganoderma lucidum strain;
4) taking the beautiful millettia root leaves, the tea leaves, the mulberry leaves and the dendrobium officinale which are sterilized in the step 1) as fermentation base materials, and inoculating the purple moringa oleifera fungus, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the purple moringa oleifera fungus comprise the following components in parts by weight: 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera and ganoderma lucidum, and fermenting for 30 days at 35 ℃ to obtain the ganoderma lucidum fermented rock tea.
Example 3
A processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, taking out and draining water, then carrying out sterilization treatment at 220 ℃ under 200 plus materials, wherein the tea leaves are oolong tea;
2) collecting Ganoderma lucidum, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma lucidum strain;
3) packaging the crushed moringa chips, sterilizing at 200-220 ℃, taking the crushed moringa chips as a fermentation base material, inoculating red ganoderma lucidum strains, culturing at 28 ℃ for 28 days with the mass ratio of the red ganoderma lucidum strains to the moringa chips being 1:100, and obtaining moringa purple ganoderma lucidum strains;
4) taking the beautiful millettia root leaves, the tea leaves, the mulberry leaves and the dendrobium officinale which are sterilized in the step 1) as fermentation base materials, and inoculating the moringa oleifera erythrorhizon bacteria, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the moringa oleifera erythrorhizon bacteria comprise the following components in parts by weight: fermenting 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera ganoderma lucidum at 33 ℃ for 30 days to obtain the ganoderma lucidum fermented oolong tea.
Example 4
A processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, fishing out and draining water, then carrying out sterilization treatment at 220 ℃ under 200 plus materials, and selecting black tea as tea leaves;
2) collecting Ganoderma lucidum, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma lucidum strain;
3) packaging the crushed moringa chips, sterilizing at 200-220 ℃, taking the crushed moringa chips as a fermentation base material, inoculating red ganoderma lucidum strains, culturing at 28 ℃ for 28 days with the mass ratio of the red ganoderma lucidum strains to the moringa chips being 1:100, and obtaining moringa purple ganoderma lucidum strains;
4) taking the beautiful millettia root leaves, the tea leaves, the mulberry leaves and the dendrobium officinale which are sterilized in the step 1) as fermentation base materials, and inoculating the moringa oleifera erythrorhizon bacteria, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the moringa oleifera erythrorhizon bacteria comprise the following components in parts by weight: fermenting 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera red ganoderma lucidum at 35 ℃ for 30 days to obtain red ganoderma lucidum fermented black tea.
Example 5
A processing technology of ganoderma lucidum fermented tea comprises the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, taking out and draining water, then carrying out sterilization treatment at 220 ℃ under 200 plus materials, and selecting white tea as tea leaves;
2) collecting Ganoderma lucidum, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma lucidum strain;
3) packaging the crushed moringa chips, sterilizing at 200-220 ℃, taking the crushed moringa chips as a fermentation base material, inoculating red ganoderma lucidum strains, culturing at 28 ℃ for 28 days with the mass ratio of the red ganoderma lucidum strains to the moringa chips being 1:100, and obtaining moringa purple ganoderma lucidum strains;
4) taking the beautiful millettia root leaves, the tea leaves, the mulberry leaves and the dendrobium officinale which are sterilized in the step 1) as fermentation base materials, and inoculating the moringa oleifera erythrorhizon bacteria, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the moringa oleifera erythrorhizon bacteria comprise the following components in parts by weight: fermenting 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera red ganoderma lucidum at 35 ℃ for 30 days to obtain the red ganoderma lucidum fermented white tea.
Table 1 shows the test report of example 1
| Inspection item | Unit of | The result of the detection |
| Aspartic acid | g/l00g | 1.37 |
| Threonine | g/l00g | 0.82 |
| Serine | g/l00g | 0.74 |
| Glutamic acid | g/l00g | 2.39 |
| Glycine | g/l00g | 0.89 |
| Alanine | g/l00g | 1.02 |
| Cystine | g/l00g | 0.04 |
| Valinic acid | g/l00g | 0.9 |
| Methionine | g/l00g | 0.09 |
| Isoleucine | g/l00g | 0.7 |
| Leucine | g/l00g | 1.39 |
| Tyrosine | g/l00g | 0.41 |
| Phenylalanine | g/l00g | 0.94 |
| Lysine | g/l00g | 0.48 |
| Histidine | g/l00g | 0.34 |
| Arginine | g/l00g | 0.85 |
| Proline | g/l00g | 1.06 |
| Total up to | g/l00g | 14.43 |
| Magnesium alloy | mg/kg | 2.24*10^3 |
| Selenium | mg/kg | 0.93 |
| Protein | g/100g | 24.8 |
| Vitamin C | mg/l00g | 23.6 |
| Salmonella | CFU/25g | Not detected out |
| Coliform group bacteria | MPN/g | <0.3 |
| Total number of moulds | CFU/g | 5 |
| Ganoderma lucidum polysaccharide (calculated as anhydrous glucose) (calculated as dry basis) | ％ | 0.94 |
| Triterpene and sterol (calculated as oleanolic acid) (calculated on a dry basis) | ％ | 0.62 |
| Residual | mg/kg | Not detected out |
As shown in Table 1, the ganoderma lucidum fermented tea prepared by the method organically combines the beneficial components in the ganoderma lucidum and the tea, is rich in various trace elements, and can play a role in assisting in treating blood diseases and protecting health of human bodies.
The present invention and its embodiments have been described above, but the description is not limited thereto, and the embodiments shown in the examples are only one embodiment of the present invention, but are not limited thereto. In conclusion, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (4)
1. A processing technology of ganoderma lucidum fermented tea is characterized by comprising the following steps:
1) firstly, putting beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale into purified water for soaking for 20-30min, fully and uniformly stirring in the soaking process, fishing out and draining water, and then sterilizing at 220 ℃;
2) collecting Ganoderma, performing aseptic separation on an aseptic operation table, inoculating the strain into potato glucose agar culture medium for activated culture, and culturing at 32 deg.C for 3 days to obtain Ganoderma mycelium;
3) bagging the crushed moringa oleifera chips, sterilizing at the temperature of 200-220 ℃, inoculating ganoderma lucidum mycelia serving as a fermentation base material, and culturing at the temperature of 28 ℃ for 28 days to obtain moringa oleifera ganoderma lucidum;
4) inoculating moringa oleifera and ganoderma lucidum into the sterilized beautiful millettia root leaves, tea leaves, mulberry leaves and dendrobium officinale of the step 1) which are used as fermentation base materials, and fermenting for 30 days at the temperature of 30-35 ℃ to obtain the ganoderma lucidum fermented tea.
2. The processing technology of the ganoderma lucidum fermented tea as claimed in claim 1, wherein the ganoderma lucidum in the step 2) is ganoderma sinense or ganoderma lucidum.
3. The processing technology of the ganoderma lucidum fermented tea as claimed in claim 1, wherein the mass ratio of ganoderma lucidum mycelia to the moringa oleifera chips in the step 3) is 1: 100.
4. The processing technology of the ganoderma lucidum fermented tea as claimed in claim 1, wherein the beautiful millettia root leaves, the tea leaves, the mulberry leaves, the dendrobium officinale and the moringa oleifera ganoderma lucidum in the step 4) comprise the following components in parts by weight: 6 parts of beautiful millettia root leaves, 2.5 parts of tea leaves, 0.5 part of mulberry leaves, 0.5 part of dendrobium officinale and 0.5 part of moringa oleifera and ganoderma lucidum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111164339.1A CN113907152A (en) | 2021-09-30 | 2021-09-30 | Processing technology of ganoderma lucidum fermented tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111164339.1A CN113907152A (en) | 2021-09-30 | 2021-09-30 | Processing technology of ganoderma lucidum fermented tea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113907152A true CN113907152A (en) | 2022-01-11 |
Family
ID=79237764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111164339.1A Pending CN113907152A (en) | 2021-09-30 | 2021-09-30 | Processing technology of ganoderma lucidum fermented tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113907152A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115336652A (en) * | 2022-08-26 | 2022-11-15 | 韶关学院 | Cultivation material and preparation method thereof, ganoderma lucidum mycelium and mulberry leaf tea and preparation method thereof |
| NL2030836B1 (en) * | 2022-02-07 | 2023-08-14 | Jingzhiyuan Ganoderma Lucidum Planting Cooperative In Hengshui Dev Zone | Ganoderma lucidum fermentative liquid food and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102356791A (en) * | 2011-09-08 | 2012-02-22 | 张越梅 | Preparation method for ganoderma lucidum tea |
| CN104543199A (en) * | 2014-12-11 | 2015-04-29 | 罗生芳 | Tea capable of clearing away heat and moistening lung and preparation method of tea |
| CN105580925A (en) * | 2015-12-11 | 2016-05-18 | 镇江市丹徒区茗缘茶叶专业合作社 | Method for fermenting tea leaves with ganoderma lucidum |
| CN106070785A (en) * | 2016-08-22 | 2016-11-09 | 操长安 | A kind of health-care black tea and processing technique thereof |
| CN106119126A (en) * | 2016-06-28 | 2016-11-16 | 黄秀英 | A kind of Moringa Ganoderma mycelium |
| CN107647009A (en) * | 2017-08-14 | 2018-02-02 | 湖南味菇坊生物科技股份有限公司 | Wave fine and soft ganoderma tea and preparation method |
-
2021
- 2021-09-30 CN CN202111164339.1A patent/CN113907152A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102356791A (en) * | 2011-09-08 | 2012-02-22 | 张越梅 | Preparation method for ganoderma lucidum tea |
| CN104543199A (en) * | 2014-12-11 | 2015-04-29 | 罗生芳 | Tea capable of clearing away heat and moistening lung and preparation method of tea |
| CN105580925A (en) * | 2015-12-11 | 2016-05-18 | 镇江市丹徒区茗缘茶叶专业合作社 | Method for fermenting tea leaves with ganoderma lucidum |
| CN106119126A (en) * | 2016-06-28 | 2016-11-16 | 黄秀英 | A kind of Moringa Ganoderma mycelium |
| CN106070785A (en) * | 2016-08-22 | 2016-11-09 | 操长安 | A kind of health-care black tea and processing technique thereof |
| CN107647009A (en) * | 2017-08-14 | 2018-02-02 | 湖南味菇坊生物科技股份有限公司 | Wave fine and soft ganoderma tea and preparation method |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2030836B1 (en) * | 2022-02-07 | 2023-08-14 | Jingzhiyuan Ganoderma Lucidum Planting Cooperative In Hengshui Dev Zone | Ganoderma lucidum fermentative liquid food and preparation method thereof |
| CN115336652A (en) * | 2022-08-26 | 2022-11-15 | 韶关学院 | Cultivation material and preparation method thereof, ganoderma lucidum mycelium and mulberry leaf tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109717340B (en) | Fermentation preparation method of two-step cordyceps militaris enzyme combined with composite enzymolysis | |
| CN113907152A (en) | Processing technology of ganoderma lucidum fermented tea | |
| CN108251265B (en) | Brewing method of lipid-lowering vinegar | |
| CN104013657A (en) | Post-fermentation extracting method of extracting saponin from American ginseng medicinal material | |
| KR20110104278A (en) | Manufacturing method of fermented materials using wax gourd and functional food of thereof manufacturing | |
| CN101715916A (en) | Method for preparing whole-wheat food containing rich edible fungus nutrient components | |
| CN107624513A (en) | It is a kind of rich in the edible and medical fungi cultural hypha method of polysaccharide and application | |
| CN101724563A (en) | Cordyceps sinensis mycelium powder and preparation method thereof | |
| WO2021031802A1 (en) | Method for producing ganoderma lucidum, radix astragali and radix codonopsis series product, and ganoderma lucidum, radix astragali and radix codonopsis series product | |
| CN105918751A (en) | Cordyceps sinensis-lactobacillus fermented beverage | |
| CN104431744A (en) | Semi-solid-state fermentation method for releasing rice bran phenolic substance | |
| CN102018259A (en) | Cordyceps sinensis and monacolin drink and preparation method thereof | |
| CN105876764A (en) | Preparation technology of fermented mushroom sauce | |
| CN110507681A (en) | A kind of technique of higher value application flower of Panax ginseng | |
| CN106923121B (en) | Coix seed active peptide beverage and preparation method thereof | |
| CN105154306A (en) | Preparation method of ganoderma lucidum healthy vinegar | |
| CN106867739A (en) | A kind of ginseng, honey grape wine and preparation method thereof | |
| CN112877173B (en) | Black tea composite poria cocos liquid state fermentation hypha health vinegar and preparation method thereof | |
| CN107753741B (en) | Method for finely and deeply processing sealwort and product thereof | |
| CN103981048B (en) | A kind of production method of Chinese yam millet wine | |
| CN106307532A (en) | Rosa roxburghii tratt composite enzyme and preparation method thereof | |
| CN106993808A (en) | A kind of Organic Lemon ferment health-care nutrient liquor and preparation method thereof | |
| CN111109413A (en) | Method for producing tartary buckwheat fungus tea by using phellinus igniarius | |
| CN1036470C (en) | Products made by mixed fermentation of mushroom and chinese herbal medicine and its method | |
| CN113088418B (en) | Morel fermented buckwheat whole-plant health wine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220111 |